Efficacy of GMA in steroid naive patients with active ulcerative colitis. -a multicenter study - - To evaluate the efficacy of GMA in steroid naive patients with active ulcerative colitis.

Osaka Medical College Hospital0 个研究点目标入组 200 人开始时间: 2014年4月13日最近更新: 2023年10月17日

试验速览

暂无简介。

•1. Re-registered patients. 2. Patients whose granulocyte count below 2,000/mm3. 3. Patients with or suspected to have severe infection. 4. Patients with serious heart disease. 5. Patients with serious kidney disorder. 6. Patients with hypotension (mamimal blood pressure below 80mmHg). 7. Pregnant patients 8. Patients with serious dehydration, serious coagulation abnormality, or serious anemia (Hb below 8.0d/dL). 9. Patients with malignancy. 10. Patients who have artificial anus. 11. Patients who have undergone intestinal operation within 12 weeks. 12. Patients who have severe extraintestinal complications. 13. Patients who have received an initial dose or an increased dose of 5-ASA agents within 2 weeks before screening. 14. Patients who have received a dose of tacrolimus within 4 weeks before screening. 15. Patients who have received cytapheresis within 4 weeks before screening. 16. Patiens who have received an initial dose or an increased dose of immunomodulators within 8 weeks before screening. 17. Patients who are judged to be ineligible by an investigator.

发起方

Osaka Medical College Hospital